V
Venmax Drugs & Pharmaceuticals
VENMAX Share Price
Healthcare26.20
as on 20 Mar 2026 at 15:12
BSE
Market Cap
₹23 Cr
PE Ratio
26.30
ROCE
-0.30%
VENMAX Fundamentals
Company Valuation
Market Cap (₹ Cr.)
23
PE Ratio
26.30
PB Ratio
2.25
Dividend Yield
-
ROE
-0.24%
ROCE
-0.30%
Book Value (₹)
11.53
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 23.14% | 23.14% | 23.14% | 23.14% | 15.14% |
| Domestic Institutional Investors (DII) | 0.15% | 0.15% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 65.54% | 65.24% | 65.01% | 65.36% | 64.25% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
VENMAX Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
531015
NSE Scrip Name
VENMAX
ISIN
INE154G01022



